Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study

Risk of Hospitalization for Cardiovascular Events with β-Blockers in Hypertensive Patients: A Retrospective Cohort Study

Abstract Introduction β-Blockers are a heterogenous class of drugs that are no longer recommended for initial antihypertension monotherapy due to unfavorable long-term cardiovascular events observed with non-vasodilatory β-blockers. However, the comparative cardiovascular event risk between the vaso...

Full description

Bibliographic Details
Main Authors: Jan Basile, Brent Egan, Henry Punzi, Sanjida Ali, Qian Li, Mehul Patel, Joel Neutel
Format: Article
Language:English
Published: Adis, Springer Healthcare 2018-09-01
Series:Cardiology and Therapy
Subjects:
Antihypertensive agents
Atenolol
Cardiovascular diseases
Metoprolol
Nebivolol
Retrospective studies
Online Access:http://link.springer.com/article/10.1007/s40119-018-0117-y

Internet

http://link.springer.com/article/10.1007/s40119-018-0117-y

Similar Items